Basics Humacyte, Inc. Common Stock IPO Date: November 30, 2020 Sector: Healthcare Industry: Biotech Market Cap: $384.69M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.89% Avg Daily Range (30 D): $0.08 | 4.51% Avg Daily Range (90 D): $0.10 | 4.31% Institutional Daily Volume Avg Daily Volume: 1.3M Avg Daily Volume (30 D): 3.98M Avg Daily Volume (90 D): 3.47M Trade Size Avg Trade Size (Sh.): 160 Avg Trade Size (Sh.) (30 D): 302 Avg Trade Size (Sh.) (90 D): 253 Institutional Trades Total Inst.Trades: 278 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $1.97M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .29M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $2.63M Avg Closing Trade (90 D): $1.14M Avg Closing Volume: 296.74K         News Mar 26, 2025 @ 10:18 AM US Stocks Likely To Open Lower After 3-Day Advance... Source: Rishabh Mishra Jan 21, 2025 @ 3:44 PM DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ... Source: The Law Offices Of Frank R. Cruz Jan 17, 2025 @ 5:28 PM HUMA Investors Have Opportunity to Lead Humacyte, ... Source: Business Wire Jan 17, 2025 @ 3:47 PM HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM,... Source: N/A Jan 13, 2025 @ 5:14 PM Humacyte, Inc. (HUMA) Investors Who Lost Money Hav... Source: Prnewswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.69 $.28 $-.16 Diluted EPS $-.69 $.28 $-.16 Revenue $ .52M $ .52M $ M Gross Profit $ $ .37M $ Net Income / Loss $ -77.67M $ 39.14M $ -20.94M Operating Income / Loss $ -111M $ -23.18M $ -28.09M Cost of Revenue $ $ .15M $ Net Cash Flow $ -2.66M $ 17.91M $ 24.37M PE Ratio